Literature DB >> 2415889

Elevated serum alpha-fetoprotein associated with Sertoli-Leydig cell tumors of the ovary.

W J Mann, J Chumas, Z Rosenwaks, J A Merrill, D Davenport.   

Abstract

Two young girls are described who presented with amenorrhea, large ovarian masses, elevated serum alpha-fetoprotein (AFP), and signs of androgen excess. Whereas the findings of an ovarian mass and elevated serum AFP typically suggest an ominous diagnosis, ie, endodermal sinus tumor of the ovary, both of these patients were found at laparotomy to have Sertoli-Leydig cell tumors of the ovary. Unilateral oophorectomy rapidly led to undetectable AFP levels in both patients, and resumption of menses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2415889

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

Review 1.  Ovarian tumors with functioning manifestations.

Authors:  Fattaneh A Tavassoli
Journal:  Endocr Pathol       Date:  1994-09       Impact factor: 3.943

2.  Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas.

Authors:  G Gitsch; P Kohlberger; E Hanzal; H Kölbl; G Breitenecker
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

Review 3.  Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.

Authors:  Mariana Horta; Teresa Margarida Cunha; Rita Canas Marques; Ana Félix
Journal:  J Radiol Case Rep       Date:  2014-11-30

4.  Immunohistochemistry of ovarian granulosa cell tumours. The value of tissue specific proteins and tumour markers.

Authors:  S Chadha; T H van der Kwast
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  α-Fetoprotein-Producing Non-Germ Cell Tumors of the Urological System.

Authors:  Mona El-Bahrawy
Journal:  Rev Urol       Date:  2011

Review 6.  [Endocrine-active tumors of the ovary].

Authors:  H-E Stegner; Th Löning
Journal:  Pathologe       Date:  2003-06-19       Impact factor: 1.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.